NCT05389046View on ClinicalTrials.gov

Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia

NARecruitingINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Outpatients / Inpatients With Depression
Interventions
DRUG

Escitalopram

Escitalopram

DRUG

Escitalopram+Aripiprazole

Escitalopram+Aripiprazole

DRUG

Escitalopram+omega-3 PUFAs

Escitalopram+omega-3 PUFAs

DRUG

Escitalopram+Aripiprazole+omega-3 PUFAs

Escitalopram+Aripiprazole+omega-3 PUFAs

Trial Locations (3)

100035

RECRUITING

Beijing Xicheng District Pingan Hosptial, Beijing

100096

RECRUITING

Beijing Huilongguan Hospital, Beijing

100191

RECRUITING

Peking University Sixth Hospital, Beijing

All Listed Sponsors
lead

Peking University

OTHER